|
1
|
Grek A and Arasi L: Acute liver failure.
AACN Adv Crit Care. 27:420–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernal W and Wendon J: Acute liver
failure. N Engl J Med. 369:2525–2534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Gou C, Yang H, Qiu J, Gu T and Wen
T: Echinacoside ameliorates D-galactosamine plus
lipopolysaccharide-induced acute liver injury in mice via
inhibition of apoptosis and inflammation. Scand J Gastroenterol.
49:993–1000. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong V, Nanchal R and Karvellas CJ:
Pathophysiology of acute liver failure. Nutr Clin Pract. 35:24–29.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Z, Han M, Chen T, Yan W and Ning Q:
Acute liver failure: Mechanisms of immune-mediated liver injury.
Liver Int. 30:782–794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Antoine DJ, Dear JW, Lewis PS, Platt V,
Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, et
al: Mechanistic biomarkers provide early and sensitive detection of
acetaminophen-induced acute liver injury at first presentation to
hospital. Hepatology. 58:777–787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song G, Sharma AD, Roll GR, Ng R, Lee AY,
Blelloch RH, Frandsen NM and Willenbring H: MicroRNAs control
hepatocyte proliferation during liver regeneration. Hepatology.
51:1735–1743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szabo G and Bala S: MicroRNAs in liver
disease. Nat Rev Gastroenterol Hepatol. 10:542–552. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XW, Heegaard NH and Orum H: MicroRNAs
in liver disease. Gastroenterology. 142:1431–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang D, Sun X, Wei Y, Liang H, Yuan M, Jin
F, Chen X, Liu Y, Zhang CY, Li L and Zen K: Nuclear miR-122
directly regulates the biogenesis of cell survival oncomiR miR-21
at the posttranscriptional level. Nucleic Acids Res. 46:2012–2029.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bandiera S, Pfeffer S, Baumert TF and
Zeisel MB: miR-122-a key factor and therapeutic target in liver
disease. J Hepatol. 62:448–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang D, Yuan Q, Balakrishnan A, Bantel H,
Klusmann JH, Manns MP, Ott M, Cantz T and Sharma AD:
MicroRNA-125b-5p mimic inhibits acute liver failure. Nat Commun.
7:119162016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Izawa T, Horiuchi T, Atarashi M, Kuwamura
M and Yamate J: Anti-fibrotic role of miR-214 in
thioacetamide-induced liver cirrhosis in rats. Toxicol Pathol.
43:844–851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng Z, Li Z, Zhu D, Ling W, Zheng L, Pu L
and Kong L: Mir-24 regulates hepatocyte apoptosis via BIM during
acute liver failure. Am J Transl Res. 9:4925–4935. 2017.PubMed/NCBI
|
|
16
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuhla A, Eipel C, Siebert N, Abshagen K,
Menger MD and Vollmar B: Hepatocellular apoptosis is mediated by
TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of
acute liver failure. Apoptosis. 13:1427–1438. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wan J, Benkdane M, Alons E, Lotersztajn S
and Pavoine C: M2 kupffer cells promote hepatocyte senescence: An
IL-6-dependent protective mechanism against alcoholic liver
disease. Am J Pathol. 184:1763–1772. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kerr TA, Korenblat KM and Davidson NO:
MicroRNAs and liver disease. Transl Res. 157:241–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen J, Lin H, Zhao M, Tao L, Yang Y, Xu X,
Jia A, Zhang J and Weng D: Piceatannol attenuates
D-GalN/LPS-induced hepatoxicity in mice: Involvement of ER stress,
inflammation and oxidative stress. Int Immunopharmacol. 64:131–139.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bian X, Liu X, Liu J, Zhao Y, Li H, Zhang
L, Li P and Gao Y: Hepatoprotective effect of chiisanoside from
Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver
injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling
pathways. J Sci Food Agric. 99:3283–3290. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang H, Chen L, Zhang X, Xu L, Xie B, Shi
H, Duan Z, Zhang H and Ren F: Kaempferol protects mice from
d-GalN/LPS-induced acute liver failure by regulating the ER
stress-Grp78-CHOP signaling pathway. Biomed Pharmacother.
111:468–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rutherford A and Chung RT: Acute liver
failure: Mechanisms of hepatocyte injury and regeneration. Semin
Liver Dis. 28:167–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schwabe RF and Luedde T: Apoptosis and
necroptosis in the liver: A matter of life and death. Nat Rev
Gastroenterol Hepatol. 15:738–752. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shirozu K, Hirai S, Tanaka T, Hisaka S,
Kaneki M and Ichinose F: Farnesyltransferase inhibitor, tipifarnib,
prevents galactosamine/lipopolysaccharide-induced acute liver
failure. Shock. 42:570–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gómez-Fernández JC: Functions of the
C-terminal domains of apoptosis-related proteins of the Bcl-2
family. Chem Phys Lipids. 183:77–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang RZ, Qiu H, Wang N, Long FL and Mao
DW: Effect of rheum palmatum L. on NF-κB signaling pathway of mice
with acute liver failure. Asian Pac J Trop Med. 8:841–847. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu L, Zheng X, Wang Y, Fan Q, Zhang M, Li
R, Ye J, Wu X, Zhao W and Zhang Y: Berberine protects acute liver
failure in mice through inhibiting inflammation and
mitochondria-dependent apoptosis. Eur J Pharmacol. 819:161–168.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakama T, Hirono S, Moriuchi A, Hasuike S,
Nagata K, Hori T, Ido A, Hayashi K and Tsubouchi H: Etoposide
prevents apoptosis in mouse liver with
D-galactosamine/lipopolysaccharide-induced fulminant hepatic
failure resulting in reduction of lethality. Hepatology.
33:1441–1450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garofalo M, Condorelli GL, Croce CM and
Condorelli G: MicroRNAs as regulators of death receptors signaling.
Cell Death Differ. 17:200–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
An F, Gong B, Wang H, Yu D, Zhao G, Lin L,
Tang W, Yu H, Bao S and Xie Q: miR-15b and miR-16 regulate TNF
mediated hepatocyte apoptosis via BCL2 in acute liver failure.
Apoptosis. 17:702–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ghaderi S, Alidadiani N, SoleimaniRad J,
Heidari HR, Dilaver N, Heim C, Ramsperger-Gleixner M, Baradaran B
and Weyand M: DJ1 and microRNA-214 act synergistically to rescue
myoblast cells after ischemia/reperfusion injury. J Cell Biochem.
119:7192–7203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu X, Li W and Li H: miR-214 ameliorates
acute kidney injury via targeting DKK3 and activating of
Wnt/β-catenin signaling pathway. Biol Res. 51:312018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X, Ha T, Hu Y, Lu C, Liu L, Zhang X,
Kao R, Kalbfleisch J, Williams D and Li C: MicroRNA-214 protects
against hypoxia/reoxygenation induced cell damage and myocardial
ischemia/reperfusion injury via suppression of PTEN and Bim1
expression. Oncotarget. 7:86926–86936. 2016. View Article : Google Scholar : PubMed/NCBI
|
